Copyright
©The Author(s) 2023.
World J Gastroenterol. Feb 28, 2023; 29(8): 1330-1343
Published online Feb 28, 2023. doi: 10.3748/wjg.v29.i8.1330
Published online Feb 28, 2023. doi: 10.3748/wjg.v29.i8.1330
Table 1 Description of most common intestinal complications related to associated diseases (International Statistical Classification of Diseases and Related Health Problems) or procedures (codes), n (%)
ICs | Description of ICs | Patients (n = 1273) | % | Procedure-related complications | Patients (n = 1125) | % | |
Associated disease (ICD-10–related complications) | 0407020403 | Abdominal rectosigmoidectomy | 167 | 15 | |||
K62 | Other diseases of the anus and rectum | 1070 | 78 | 0407020390 | Body removed – rectum or colon polyps | 145 | 13 |
C18 | Malignant neoplasms of the colon | 255 | 19 | 0407020063 | Partial colectomy | 135 | 12 |
K59 | Other functional intestinal disorders | 66 | 5 | 0407020209 | Enteroctomy and/or resection | 128 | 11 |
L52 | Erythema nodosum | 27 | 2 | 0407020101 | Colostomy | 105 | 9 |
K56 | Paralytic ileus and intestinal obstruction without hernia | 3 | 0.2 | 0407020128 | Dilatation of the anus and/or rectum | 91 | 8 |
K51 | Ulcerative colitis | 2 | 0.1 | 0407020098 | Abdominal colporrhaphy | 51 | 5 |
C63 | Malignant neoplasms of other and unspecified male genital organs | 1 | 0.1 | 0407020241 | Enterostomy closure | 50 | 4 |
0407020187 | Enteroanastomy | 41 | 4 |
Table 2 Demographic characteristics and follow-up of patients with ulcerative colitis treated with conventional therapies, n (%)
Variable | n | % |
Patients | 41229 | 100 |
Age1, yr | ||
mean ± SD | 48.86 ± 15.42 | |
Median (IQI) | 48.09 (60.15-36.94) | |
Sex | ||
Male | 14417 | 35 |
Female | 26812 | 65 |
Ethnicity | ||
White | 23290 | 56 |
Black and other | 11987 | 33 |
Missing | 4643 | 11 |
CVT initiation | ||
2011 | 4300 | 10 |
2012 | 4054 | 10 |
2013 | 4259 | 10 |
2014 | 4877 | 12 |
2015 | 4846 | 12 |
2016 | 5039 | 12 |
2017 | 5565 | 13 |
2018 | 5040 | 12 |
2019 | 3249 | 8 |
Follow-up time2, yr | ||
mean ± SD | 3.65 (2.27) | |
Median (IQI) | 3.25 (1.75-5.26) | |
Region of residence | ||
Southeast | 22942 | 56 |
South | 8831 | 21 |
Midwest | 2638 | 6 |
Northeast | 5833 | 14 |
North | 985 | 2 |
Missing | 0 | 0 |
Patients under CVT | ||
Mesalazine | 35923 | 87 |
Sulfasalazine | 6148 | 15 |
Azathioprine | 6413 | 16 |
Ciclosporine | 116 | 0 |
Methotrexate | 290 | 1 |
Time using CVT3, yr | ||
mean ± SD | 2.64 (2.29) | |
Median (IQI) | 1.92 (0.75-4.00) | |
Patients switched treatment after first IC4 | 2564 | 6 |
Time to switch treatment after IC, yr | ||
mean ± SD | 0.36 (0.76) | |
Median (IQI) | 0.08 (0.08-0.25) | |
Min | 0.08 |
Table 3 Incidence of intestinal complications (overall and segregated types) in patients with ulcerative colitis considering all population at risk
Table 4 Annual incidence of intestinal complications (overall and segregated type) in patients with ulcerative colitis over the study period (January 2011-February 2020)
Overall | Associated disease (ICD-10–related) | Procedure-related | UC-related hospitalization | |||||||||||||
Patients (n) | % | Claims (n) | mean ± SD | Patients (n) | % | Claims (n) | mean ± SD | Patients (n) | % | Claims (n) | mean ± SD | Patients (n) | % | Claims (n) | mean ± SD | |
≤ 1 yr (n = 41229) | 1197 | 2.90 | 1582 | 1.32 ± 1.3 | 487 | 1.18 | 763 | 1.57 ± 1.92 | 293 | 0.71 | 312 | 1.06 ± 0.29 | 456 | 1.10 | 520 | 1.14 ± 0.44 |
2 yr (n = 36389) | 931 | 2.56 | 1250 | 1.34 ± 1.35 | 355 | 0.98 | 601 | 1.69 ± 2.08 | 262 | 0.72 | 284 | 1.08 ± 0.36 | 343 | 0.94 | 376 | 1.1 ± 0.32 |
3 yr (n = 28795) | 716 | 2.49 | 953 | 1.33 ± 1.39 | 305 | 1.06 | 493 | 1.62 ± 2.05 | 182 | 0.63 | 201 | 1.1 ± 0.34 | 242 | 0.84 | 263 | 1.09 ± 0.34 |
4 yr (n = 22012) | 531 | 2.41 | 668 | 1.26 ± 1.16 | 219 | 0.99 | 323 | 1.47 ± 1.72 | 158 | 0.72 | 170 | 1.08 ± 0.37 | 163 | 0.74 | 177 | 1.09 ± 0.32 |
5 yr (n = 16510) | 389 | 2.36 | 457 | 1.17 ± 0.88 | 146 | 0.88 | 190 | 1.3 ± 1.36 | 113 | 0.68 | 115 | 1.02 ± 0.13 | 139 | 0.84 | 155 | 1.12 ± 0.36 |
Table 5 Length of hospitalization and most common procedures performed during hospitalization
Length of hospitalization and procedures | mean ± SD | Median (IQI) | Procedures (inpatient most common procedures1) | Patients (n = 1426) | % | |
ICs | Description of ICs | |||||
Hospitalization (inpatient) | 303070099 | Treatment of enteritis and colitis not infectious | 1103 | 77 | ||
Length of hospital stay, d (PPPY) | 6.62 ± 6.62 | 4.60 (2.63-8.11) | 301060088 | Diagnose and/or emergence care in medical clinic | 102 | 7 |
Number of procedures performed (PPPY) | 0.32 ± 0.28 | 0.23 (0.15-0.38) | 303070110 | Treatment of other intestinal diseases | 56 | 4 |
301060070 | Diagnosis and/or emergence care in surgery clinic | 47 | 3 | |||
415010012 | Treatment with multiple surgeries | 44 | 3 | |||
415020034 | Other procedures with following surgeries | 30 | 2 | |||
407020071 | Total colectomy | 29 | 2 | |||
303070102 | Treatment of digestive tract disease | 23 | 2 | |||
407020330 | Total proctocolectomy | 12 | 1 | |||
303010061 | Exploratory laparotomy | 9 | 1 |
- Citation: Martins AL, Galhardi Gasparini R, Sassaki LY, Saad-Hossne R, Ritter AMV, Barreto TB, Marcolino T, Yang Santos C. Intestinal complications in Brazilian patients with ulcerative colitis treated with conventional therapy between 2011 and 2020. World J Gastroenterol 2023; 29(8): 1330-1343
- URL: https://www.wjgnet.com/1007-9327/full/v29/i8/1330.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i8.1330